Ionis Pharmaceuticals IONS Current State And Local Tax Expense Benefit
Current State And Local Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CurrentStateAndLocalTaxExpenseBenefit.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's current state and local tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's current state and local tax expense benefit?
- Ionis Pharmaceuticals (IONS) reported current state and local tax expense benefit of $645K in Q4 2025.
- How has Ionis Pharmaceuticals's current state and local tax expense benefit changed year-over-year?
- Ionis Pharmaceuticals's current state and local tax expense benefit increased by 404.2% year-over-year, from -$212K to $645K.
- What is the long-term trend for Ionis Pharmaceuticals's current state and local tax expense benefit?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's current state and local tax expense benefit has grown at a -16.3% compound annual growth rate (CAGR), from -$3.69M to $2.58M.
- What does current state and local tax expense benefit mean?
- The current period's income tax expense owed to state and local governments.
- How do you interpret current state and local tax expense benefit?
- Increases may reflect higher profitability in specific states or changes in state-level tax legislation.
- How does current state and local tax expense benefit compare across companies?
- Standard tax disclosure for companies with significant domestic operations across multiple states.